Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis

Recent Advances in Anti-Angiogenic Therapy of Cancer

(2015) Rajeev S. Samant et al.   Oncotarget

Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts

(2012) Huan Tong et al.   Journal of Digestive Diseases

Therapeutic targets in liver fibrosis

(2011) Jonathan A. Fallowfield   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts

(2011) Yan Xie et al.   CANCER BIOLOGY & THERAPY

Celecoxib

(2011) Paul L. McCormack   DRUGS

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis

(2011) Dominique Thabut et al.   HEPATOLOGY

Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice

(2011) Christophe Van Steenkiste et al.   HEPATOLOGY

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension

(2010) Jaume Bosch et al.   JOURNAL OF HEPATOLOGY

Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?

(2010) Dominique Thabut et al.   JOURNAL OF HEPATOLOGY

The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats

(2010) Jun Yu et al.   LIVER INTERNATIONAL

Cyclooxygenase-2 Expression in Chronic Liver Diseases and Hepatocellular Carcinoma

(2009) Lydia Giannitrapani et al.   Annals of the New York Academy of Sciences

Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats

(2009) Y-H Paik et al.   GUT

Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis

(2009) Eleonora Patsenker et al.   HEPATOLOGY

Adverse effects of anticancer agents that target the VEGF pathway

(2009) Helen X. Chen et al.   Nature Reviews Clinical Oncology

Current and Future Anti-Fibrotic Therapies for Chronic Liver Disease

(2008) Don C. Rockey   Clinics in Liver Disease

Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis

(2008) Kojiro Taura et al.   GASTROENTEROLOGY

Mechanisms of Hepatic Fibrogenesis

(2008) Scott L. Friedman   GASTROENTEROLOGY

Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

(2008) Marc Mejias et al.   HEPATOLOGY

Celecoxib exacerbates hepatic fibrosis and induces hepatocellular necrosis in rats treated with porcine serum

(2008) Hao Liu et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS